Follow
David J Hawellek
David J Hawellek
F. Hoffmann-La Roche Ltd.
Verified email at roche.com
Title
Cited by
Cited by
Year
Large-scale cortical correlation structure of spontaneous oscillatory activity
JF Hipp, DJ Hawellek, M Corbetta, M Siegel, AK Engel
Nature neuroscience 15 (6), 884-890, 2012
10562012
Increased functional connectivity indicates the severity of cognitive impairment in multiple sclerosis
DJ Hawellek, JF Hipp, CM Lewis, M Corbetta, AK Engel
Proceedings of the National Academy of Sciences 108 (47), 19066-19071, 2011
3102011
Altered intrinsic neuronal interactions in the visual cortex of the blind
DJ Hawellek, IM Schepers, B Roeder, AK Engel, M Siegel, JF Hipp
Journal of Neuroscience 33 (43), 17072-17080, 2013
472013
Temporal coding of reward-guided choice in the posterior parietal cortex
DJ Hawellek, YT Wong, B Pesaran
Proceedings of the National Academy of Sciences 113 (47), 13492-13497, 2016
442016
EEG based brain-machine interface for navigation of robotic device
M Mahmud, D Hawellek, A Bertoldo
2010 3rd IEEE RAS & EMBS International Conference on Biomedical Robotics and …, 2010
332010
A brain-machine interface based on eeg: Extracted alpha waves applied to mobile robot
M Mahmud, D Hawellek, A Valjamae
2009 Advanced Technologies for Enhanced Quality of Life, 28-31, 2009
172009
Towards automated recognition of facial expressions in animal models
G Blumrosen, D Hawellek, B Pesaran
Proceedings of the IEEE International Conference on Computer Vision …, 2017
142017
Impairment of GABA transporter GAT-1 terminates cortical recurrent network activity via enhanced phasic inhibition
DS Razik, DJ Hawellek, B Antkowiak, H Hentschke
Frontiers in neural circuits 7, 141, 2013
92013
Switching between visuomotor mappings: learning absolute mappings or relative shifts
LCJ van Dam, DJ Hawellek, MO Ernst
Journal of Vision 13 (2), 26-26, 2013
92013
Changes in brain activity with tominersen in early-manifest Huntington’s disease
DJ Hawellek, P Garces, AH Meghdadi, S Waninger, A Smith, ...
Brain Communications 4 (3), fcac149, 2022
82022
Tominersen in adults with manifest Huntington's disease
P McColgan, A Thobhani, L Boak, SA Schobel, A Nicotra, G Palermo, ...
The New England journal of medicine 389 (23), 2203-2205, 2023
52023
Motion coherence and luminance contrast interact in driving visual gamma-band activity
F Pellegrini, DJ Hawellek, AA Pape, JF Hipp, M Siegel
Cerebral Cortex 31 (3), 1622-1631, 2021
32021
Quantifying mutant huntingtin protein in human cerebrospinal fluid to support the development of huntingtin-lowering therapies
S Vauleon, K Schutz, B Massonnet, N Gruben, M Manchester, A Buehler, ...
Scientific Reports 13 (1), 5332, 2023
12023
Neural representations of the content and production of human vocalization
VA Voigtlaender, F Sandhaeger, DJ Hawellek, SR Hage, M Siegel
Proceedings of the National Academy of Sciences 120 (23), e2219310120, 2023
2023
E10 Cross-sectional exploration of the clinical utility of brain age as an imaging-based marker of disease pathology in Huntington’s disease (HD) based on the tominersen phase …
DJ Hawellek, DA Engemann, S Holiga, A Napolitano, M Abaei, ...
Journal of Neurology, Neurosurgery & Psychiatry 93 (Suppl 1), A35-A35, 2022
2022
BRAIN COMMUNICATIONS AIN COMMUNICATIONS
DJ Hawellek, P Garces, AH Meghdadi, S Waninger, A Smith, ...
2022
Comparison of correlations of structural magnetic resonance imaging measures with smartphone-based active tests and clinical tests in Huntington’s disease
J Rennig, D Hawellek, J Dorn, F Lipsmeier, S Holiga, C Simillion, ...
MOVEMENT DISORDERS 36, S107-S107, 2021
2021
Validation of smartphone-based active tests with structural neuroimaging in Huntington’s disease
J Rennig, S Holiga, D Hawellek, F Lipsmeier, J Dorn, S Schobel, ...
MOVEMENT DISORDERS 36, S106-S107, 2021
2021
D01 Two independent validations of a mutant huntingtin protein (MHTT) assay to support the clinical development of mHTT-targeting therapies in HD
D Hawellek, S Vauleon, K Schutz, B Massonnet, N Gruben, M Manchester, ...
Journal of Neurology, Neurosurgery & Psychiatry 92 (Suppl 1), A13-A13, 2021
2021
Quantification of Mutant Huntingtin Protein (mHTT) in Human Cerebrospinal Fluid to Support Clinical Development of mHTT-Targeting Therapies in Huntington's Disease
K Schutz, A Buehler, E Schick, MM Young, L Boak, SA Schobel, ...
NEUROTHERAPEUTICS 17 (SUPPL 1), 23-24, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20